Students in North Carolina are about to get their own Magic School Bus. Ten Boys and Girls Clubs throughout North Carolina will spend a week with an interactive science vehicle through a partnership with the Morehead Planetarium and GlaxoSmithKline.
The initiative, named “Science On Your Street,” consists of a van containing interactive technologies and experiments for children, including 3D printers and robots. The curriculum, designed by employees of Morehead Planetarium, focuses on engineering and technology.
The Brentwood Boys and Girls Club in downtown Raleigh was the first stop Sept. 26 — the first day of the initiative.
“It went really well,” Glenda Hairston, the Morehead Planetarium's Outreach Science Programs manager said. “The kids did an activity centered around littleBits, which we call electronic Legos. Kids can design their own electronic devices like circuits out of simple materials to power mini fans.”
According to Marti Skold-Jordan, the GSK U.S. Community Partnerships manager, many school districts spend less than an hour a week on science education. “Science On Your Street” serves as a conduit for children who don’t have access to interactive technologies in classrooms, museums or other educational facilities.
“We want to inspire all kids to learn to love science,” Jordan said. “We want kids to know that science is magic. Science is an adventure.”
Jordan expects a long term impact from the program. With a workforce that increasingly demands STEM skills, Jordan said it is important that children become fluent in science and technology from an early age.
“The jobs of the next generation are going to be in STEM,” Jordan said. “No matter what you touch everyday, whether it be your cell phone, your smart car, from taking your pill in the morning, everything we touch during the day has some sort of STEM component. Even if (the kids) are not going into STEM, they need to be STEM literate, because that’s what their world is.”
"Science On Your Street" is the newest addition to the science education programs that GSK funds.